Labcorp Acquires Certain BioReference Health Laboratory Assets for $237.5M
March 28, 2024
Labcorp will acquire certain laboratory testing businesses and operating assets from Opko Health subsidiary BioReference Health for $237.5 million. The assets — which generate roughly $100 million in annual revenue — include patient service centers and select customer contracts across the U.S. (excluding New York and New Jersey); BioReference Health will retain its oncology and urology diagnostic businesses and full operations in New York and New Jersey. The transaction is expected to close in the second half of 2024, subject to customary conditions and regulatory approvals.
- Buyers
- Labcorp
- Targets
- BioReference Health
- Sellers
- Opko Health, BioReference Health
- Industry
- Healthcare Services
- Location
- New Jersey, United States
- Transaction Type
- Divestiture
Explore More
Related Acquisitions
-
Labcorp Acquires RWJBarnabas Health Outreach Laboratory Business
August 23, 2022
Healthcare Services
Labcorp has closed the acquisition of RWJBarnabas Health’s outreach laboratory business and select related assets, expanding Labcorp’s diagnostic footprint and patient access across New Jersey. The deal transfers RWJBarnabas Health’s outreach testing operations to Labcorp to provide an expanded test menu, enhanced connectivity, and broader patient service coverage; terms were not disclosed.
-
Labcorp Acquires North Mississippi Health Services' Ambulatory Outreach Laboratory Business
April 21, 2025
Healthcare Services
Labcorp has completed the acquisition of North Mississippi Health Services' ambulatory outreach laboratory business and will become the referral laboratory for NMHS's seven hospitals and clinic laboratories. Labcorp plans to open three new patient service centers in Tupelo, West Point and Amory to increase access to laboratory services and provide continuity of care, data tools and expanded testing capabilities in North Mississippi.
-
Clinical Reference Laboratory Acquires Confirm BioSciences
December 9, 2020
Healthcare Services
Clinical Reference Laboratory (CRL), a large privately held clinical testing laboratory, has acquired Confirm BioSciences, a San Diego–based provider of screening tools and consumer-facing testing products. The acquisition will have Confirm operate as a subsidiary and is intended to expand CRL's lab testing and R&D capabilities while leveraging Confirm's large retail/customer base and COVID-19 testing pipeline.
-
Quest Diagnostics Acquires LifeLabs from OMERS for CAN$1.35B
July 8, 2024
Healthcare Services
Quest Diagnostics has agreed to acquire LifeLabs from Canadian pension fund OMERS for approximately CAN$1.35 billion (approximately USD $985 million), including net debt. LifeLabs will retain its brand, Toronto-area headquarters, and management, and Quest expects the acquisition to expand its diagnostic footprint in Canada while enhancing service offerings and data security.
-
Quest Diagnostics Acquires Labtech Diagnostics
December 14, 2021
Healthcare Services
Quest Diagnostics has acquired substantially all assets of Labtech Diagnostics, an independent clinical diagnostic laboratory based in Anderson, South Carolina. The acquisition brings Labtech into Quest’s national laboratory network — Quest’s first full-service laboratory in South Carolina — and expands Quest’s diagnostic capabilities and presence across the Southeast.
-
Discovery Life Sciences Acquires ReachBio Research Labs
April 11, 2023
Biotechnology
Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.